Johns Hopkins University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count).

1,448 total trials 250 currently recruiting 943 completed early-phase tilt top decile by trial count

Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.

Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.

Top-decile sponsor footprint

Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,448 total, page 26 of 29

COMPLETED Phase 3

Atkins Plus KetoCal for Childhood Epilepsy

NCT00681239

COMPLETED NA

Randomized Trial Of Achieving Healthy Lifestyles In Psych Rehabilitation

NCT00902694

COMPLETED

Monitoring of Cerebral Blood Flow Autoregulation Using Near Infrared Spectroscopy

NCT00769691

COMPLETED NA

Intensive Meditation and Migraines: Effects on Health and Well Being

NCT00663585

COMPLETED NA

Sleep in Osteoarthritis Project

NCT00592449

COMPLETED NA

Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission

NCT01053741

COMPLETED NA

Evaluating Weight Loss Programs for Obese People at Risk for Heart Disease (The POWER Study)

NCT00783315

COMPLETED NA

Parenting Videos In Primary Care

NCT00558987

COMPLETED Phase 2

Study of Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit

NCT00549393

COMPLETED

Analysis of Reporting of Cutaneous Toxicities Associated With Immune Checkpoint Inhibitors

NCT04898751

COMPLETED

Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD)

NCT00889447

COMPLETED Phase 2

Paracervical Block in First Trimester Surgical Abortions

NCT00617097

COMPLETED Phase 2

The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot

NCT00605423

COMPLETED NA

The Specificity of Cervical Facet Medial Branch Blocks

NCT00613340

TERMINATED Phase 4

Impact of Antibiotic Treatment on Prostate-Specific Antigen (PSA) Variability

NCT00596453

TERMINATED Phase 2

Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly

NCT00807365

COMPLETED Phase 3

Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide

NCT00600028

COMPLETED NA

Preventing Long Term Psychiatric Disability Among Those With Major Burn Injuries

NCT00988104

COMPLETED

Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials

NCT00719446

TERMINATED Phase 2

The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients

NCT00791076

COMPLETED NA

Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women

NCT00127231

COMPLETED NA

Mindfulness-based Stress Reduction for Urban Youth

NCT00661271

COMPLETED NA

Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation

NCT00721136

COMPLETED Phase 1

Culturally Tailored Behavioral Diabetes Care Intervention for Korean Americans

NCT00505960

COMPLETED NA

Long-term Topical Cyclosporine for Atopic Keratoconjunctivitis

NCT00987467

COMPLETED

Stress and Vision Fluctuations in Retinitis Pigmentosa

NCT00475254

COMPLETED NA

The Effect of Omalizumab on Responses to Cat Allergen Challenge

NCT00604786

COMPLETED NA

Enema Use and Acceptability in HIV Negative Men Who Have Sex With Men

NCT00696618

COMPLETED NA

A Trial of an Augmented Exercise Program in the Prevention of Deconditioning Among Survivors of Severe Burns

NCT01105637

COMPLETED

Transoral Endoscopic Liver Biopsy During Laparoscopic Gastric Bypass

NCT00512512

COMPLETED NA

Pulmonary Vein (PV) Isolation Versus Box Isolation for the Treatment of Atrial Fibrillation

NCT01091597

TERMINATED Phase 1

Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine

NCT00460759

COMPLETED

Fetal Neurobehavior in Poly-drug Dependent Women

NCT00653692

COMPLETED Phase 2

Evaluation of Blood as a Submucosal Cushion During Endoscopic Polypectomy and Mucosal Resection

NCT00583466

TERMINATED Phase 2

The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body Composition

NCT00686972

COMPLETED Phase 3

Confocal Endomicroscopy for Barrett's Esophagus

NCT00487695

COMPLETED Phase 2

Psychopharmacology of Psilocybin in Cancer Patients

NCT00465595

COMPLETED Early Phase 1

Baclofen Treatment of Ataxia Telangiectasia

NCT00640003

COMPLETED Phase 3

A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon

NCT00498615

COMPLETED Early Phase 1

A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides

NCT00389311

TERMINATED Phase 4

A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma

NCT00461812

COMPLETED NA

Randomized Study Comparing Fluoroscopically-Guided Versus Blinded Trochanteric Bursa Injections

NCT00480675

COMPLETED Phase 2

Research Study of Bipolar Mood Symptoms and Cognitive Problems

NCT00428298

COMPLETED NA

Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses

NCT00458094

COMPLETED Phase 1

Improving Outcomes Following Limb Loss: PALS Plus

NCT00447655

COMPLETED Phase 4

Lansoprazole to Treat Children With Asthma

NCT00442013

COMPLETED Phase 2

Clinical Trial of Topiramate for Cocaine Addiction

NCT00685178

COMPLETED Phase 1

Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy Subjects

NCT00344123

COMPLETED Phase 3

Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy

NCT00436631

COMPLETED NA

Efficacy and Cost: Benefit Ratio of 0, 1, and 2 Medial Branch Blocks for Lumbar Facet Joint Radiofrequency Denervation

NCT00484159

← Previous Page 26 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 201
Phase 2 198
Phase 3 44
Phase 4 81

What is open in the Johns Hopkins University pipeline

250 recruiting of 1,448 indexed (17% open); 943 completed (65%).

Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).

Top condition: Hypertension (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.